🔎 Trials Near Me

Beranda › Leukemia Limfositik Kronis › Utah › Salt Lake City

Uji klinis Leukemia Limfositik Kronis di Salt Lake City, UT

10 studi untuk Leukemia Limfositik Kronis mencari peserta di lokasi sekitar Salt Lake City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Menerima pesertaFase 3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT04269902

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Menerima pesertaFase 3
  • Huntsman Cancer Institute, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07277231

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Menerima pesertaFase 2
  • University of Utah, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07221500

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

Menerima pesertaFase 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07061951

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Menerima pesertaFase 1
  • Huntsman Cancer Institute at The University of Utah, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05091424

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Menerima pesertaFase 1
  • University of Utah, Salt Lake City
Usia 13 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT04771572

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

Menerima pesertaFase 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT05183854

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Menerima pesertaFase 1
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT04830137

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Menerima pesertaFase 2
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Des 2025 · NCT04844528

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Menerima pesertaFase 1/2
  • University of Utah, Salt Lake City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT05643742

Uji klinis Leukemia Limfositik Kronis di kota lain

Studi lain di Salt Lake City

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.